A detailed history of Geneos Wealth Management Inc. transactions in Amgen Inc stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 7,451 shares of AMGN stock, worth $1.97 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
7,451
Previous 3,896 91.25%
Holding current value
$1.97 Million
Previous $1.22 Million 97.21%
% of portfolio
0.09%
Previous 0.05%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $1.1 Million - $1.2 Million
3,555 Added 91.25%
7,451 $2.4 Million
Q2 2024

Jul 23, 2024

BUY
$262.75 - $319.31 $562,547 - $683,642
2,141 Added 121.99%
3,896 $1.22 Million
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $62,646 - $75,622
-233 Reduced 11.72%
1,755 $498,000
Q4 2023

Jan 26, 2024

SELL
$255.7 - $288.46 $114,553 - $129,230
-448 Reduced 18.39%
1,988 $572,000
Q3 2023

Oct 11, 2023

BUY
$218.65 - $271.46 $2,623 - $3,257
12 Added 0.5%
2,436 $654,000
Q2 2023

Aug 08, 2023

SELL
$214.27 - $253.37 $226,697 - $268,065
-1,058 Reduced 30.38%
2,424 $538,000
Q1 2023

Apr 25, 2023

SELL
$225.79 - $275.2 $215,177 - $262,265
-953 Reduced 21.49%
3,482 $841,000
Q4 2022

Jan 30, 2023

BUY
$229.03 - $291.01 $162,153 - $206,035
708 Added 19.0%
4,435 $1.16 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $1.34 Million - $1.51 Million
-5,968 Reduced 61.56%
3,727 $840,000
Q2 2022

Jul 22, 2022

BUY
$230.71 - $256.74 $480,107 - $534,275
2,081 Added 27.33%
9,695 $2.36 Million
Q1 2022

May 16, 2022

SELL
$219.27 - $242.57 $540,939 - $598,420
-2,467 Reduced 24.47%
7,614 $1.84 Million
Q4 2021

Feb 09, 2022

BUY
$198.88 - $227.6 $45,543 - $52,120
229 Added 2.32%
10,081 $2.27 Million
Q3 2021

Nov 09, 2021

BUY
$212.27 - $248.7 $2,971 - $3,481
14 Added 0.14%
9,852 $2.11 Million
Q2 2021

Jul 08, 2021

SELL
$233.58 - $259.14 $812,391 - $901,288
-3,478 Reduced 26.12%
9,838 $2.45 Million
Q1 2021

Jun 17, 2021

SELL
$221.91 - $258.6 $46,601 - $54,306
-210 Reduced 1.55%
13,316 $3.19 Million
Q4 2020

May 19, 2021

BUY
$216.38 - $257.67 $931,299 - $1.11 Million
4,304 Added 46.67%
13,526 $2.89 Million
Q3 2020

Sep 07, 2021

SELL
$234.65 - $260.95 $424,481 - $472,058
-1,809 Reduced 16.4%
9,222 $2.25 Million
Q2 2020

Sep 07, 2021

BUY
$197.81 - $242.74 $4,351 - $5,340
22 Added 0.2%
11,031 $2.57 Million
Q1 2020

Sep 07, 2021

SELL
$182.24 - $241.7 $4.66 Million - $6.19 Million
-25,593 Reduced 69.92%
11,009 $2.18 Million
Q4 2019

Sep 07, 2021

SELL
$189.21 - $243.2 $8,325 - $10,700
-44 Reduced 0.12%
36,602 $8.84 Million
Q3 2019

Sep 07, 2021

SELL
$174.11 - $208.62 $39,697 - $47,565
-228 Reduced 0.62%
36,646 $7.14 Million
Q2 2019

Sep 07, 2021

BUY
$166.7 - $195.41 $339,234 - $397,659
2,035 Added 5.84%
36,874 $6.8 Million
Q1 2019

Sep 07, 2021

SELL
$180.87 - $203.88 $363,006 - $409,187
-2,007 Reduced 5.45%
34,839 $6.62 Million
Q4 2018

Sep 07, 2021

SELL
$178.4 - $208.25 $340,208 - $397,132
-1,907 Reduced 4.92%
36,846 $7.03 Million
Q3 2018

Sep 07, 2021

BUY
$185.29 - $208.89 $114,138 - $128,676
616 Added 1.62%
38,753 $8.03 Million
Q2 2018

Sep 07, 2021

BUY
$166.05 - $186.51 $168,540 - $189,307
1,015 Added 2.73%
38,137 $7.04 Million
Q1 2018

Sep 07, 2021

BUY
$169.43 - $198.0 $181,290 - $211,860
1,070 Added 2.97%
37,122 $6.33 Million
Q4 2017

Sep 07, 2021

BUY
$168.79 - $188.59 $147,353 - $164,639
873 Added 2.48%
36,052 $6.27 Million
Q3 2017

Sep 07, 2021

BUY
$167.29 - $191.0 $63,570 - $72,580
380 Added 1.09%
35,179 $6.56 Million
Q2 2017

Sep 07, 2021

BUY
N/A
3,975 Added 12.9%
34,799 $6.01 Million
Q1 2017

Sep 07, 2021

BUY
N/A
21,555 Added 232.55%
30,824 $5.08 Million
Q4 2016

Sep 07, 2021

BUY
N/A
271 Added 3.01%
9,269 $1.36 Million
Q3 2016

Sep 07, 2021

SELL
N/A
-295 Reduced 3.17%
8,998 $1.5 Million
Q2 2016

Sep 07, 2021

BUY
N/A
609 Added 7.01%
9,293 $1.43 Million
Q1 2016

Sep 07, 2021

BUY
N/A
8,684
8,684 $1.34 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.